The clinical trial of TSO, Trichuris suis ova or CNDO-201, will be a randomized, double-blind, placebo-controlled, multicenter study involving 250 Chrohn’s disease patents.
More Articles on Gastroenterology:
14 Top Symptoms Leading to Gastroenterology Outpatient Visits
Dr. Carol-Lee Collins Joins KRMC in Arizona
La Peer Health Systems Launches Barrett’s Esophagus Center of Excellence
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
